Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,72 USD | -2,51% | -10,82% | -89,05% |
14/05 | RAPT THERAPEUTICS, INC. : Wolfe Research rivede il giudizio che diventa Neutral | ZM |
10/05 | RAPT THERAPEUTICS, INC. : Guggenheim rivede il giudizio che diventa Neutral | ZM |
Attività
Numero di dipendenti: 126
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 01/08/15 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 02/12/19 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 04/05/22 |
William Ho
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/15 |
Dirk Brockstedt
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/18 |
Nipun Davar
CTO | Chief Tech/Sci/R&D Officer | - | 13/02 |
Investor Relations Contact | 63 | - | |
General Counsel | - | 03/05/23 | |
Adnan Rahman
PRN | Corporate Officer/Principal | - | 28/09/22 |
Shari L. Geffon
PRN | Corporate Officer/Principal | - | 04/05/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 04/12/19 |
William Rieflin
CHM | Chairman | 64 | 01/05/15 |
Wendye Robbins
BRD | Director/Board Member | 63 | 22/10/19 |
Brian Wong
CEO | Chief Executive Officer | 52 | 01/08/15 |
Michael Giordano
BRD | Director/Board Member | 66 | 01/01/18 |
Linda Kozick
BRD | Director/Board Member | 66 | 01/12/16 |
Director/Board Member | 46 | 09/11/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 34 799 702 | 32 933 918 ( 94,64 %) | 0 | 94,64 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-89,05% | 97,38 Mln | |
+15,58% | 122 Mrd | |
+16,60% | 113 Mrd | |
+17,55% | 26,22 Mrd | |
-24,33% | 19,01 Mrd | |
-19,14% | 15,71 Mrd | |
-17,95% | 15,22 Mrd | |
-46,81% | 14,72 Mrd | |
+58,78% | 14,58 Mrd | |
+4,91% | 13,84 Mrd |
- Borsa valori
- Azioni
- Azione RAPT
- Società RAPT Therapeutics, Inc.